FDA Investigator Rochelle L Cross
Rochelle L Cross has conducted inspections on 34 sites in 10 countries as of 13 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
34
Last Inspection Date:
13 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
Canada,
France,
India,
Ireland,
United States of America,
Finland,
Belgium,
Germany,
Switzerland
FDA Investigators that have inspected at least one site in common with Rochelle L Cross:
Alan P Kurtzberg,
Alanna L Mussawwir Bias,
Alicia M Mozzachio,
Amy M Cramer,
Anastasia M Shields,
Angela E Glenn,
Anna Lazar,
Anthony A Charity,
Arsen Karapetyan,
Ashar P Parikh,
Azeezat M Lawal,
Azza Talaat,
Barbara Jwilimczyk Macri,
Barry Rothman,
Bonita S Chester,
Carrie A Hughes,
CDR Ileana Barreto Pettit,
Charisse K Green,
Charles M Edwards,
Charles R Cote, RIC,
Christian F Gomez Lugo,
Christina K Theodorou,
Christine W Twohy,
Concepcion Cruz, Jr,
Daniel J Grabicki,
Daniel J Roberts,
David A Oluwo,
Dell S Moller,
Devon Jenkins,
Djamila Harouaka,
Douglas C Kovacs,
Dr. Robert C Horan, MD,
Dr. S Nar Ali, PhD,
Edwin Martinez,
Elizabeth D Connell,
Emest F Bizjak,
Eric L Dong, BS,
Erika V Butler,
Farhana Khan,
Francis A Guidry,
Frederick F Razzaghi,
Gam S Zamil,
Gayle S Lawson,
Grace E Mcnally,
Gwyn G Dickinson,
Hung H Do, MS,
Ivis L Negron,
Jacob M Dyer,
James P Mcreavey,
John A Gonzalez,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Jorge L Guadalupe,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Joseph F Mcginnis, RPh,
Joseph L Despins, PhD,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Karen Takahashi,
Katherine Szestypalow,
Kathryn E Ogger,
Kelli F Dobilas,
Kellia N Hicks,
Kenneth H Williams,
Kent C Faul,
Kevin P Foley,
Kham Phommachanh,
Kimberley A Hoefen,
Kristy A Zielny,
Krystyna M Kitson,
Larry K Austin,
Lata C Mathew, PhD,
Latorie S Jones,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
Liatte Kreuger, PharmD,
Lisa L Flores,
Loretta Nemchik,
Lori M Newman,
Luella J Rossi,
Luis A Dasta,
Marcelo O Mangalindan, Jr,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Marie A Fadden,
Mary E Storch,
Michael R Goga,
Michele L Obert,
Michele Perry Williams,
Miguel A Martinez Perez,
Monica M Mcclure,
Mra Davism,
Mra Mcculloughj,
Nadeem I Chaudhry,
Nancy M Espinal,
Nicholas L Hunt,
Nicholas L Paulin,
Nicole E Knowlton,
Niketa Patel,
Noreen Muñiz,
Pankaj H Amin,
Parul M Patel,
Patrick C Klotzbuecher,
Patsy J Domingo,
Patty P Kaewussdangkul,
Paul A Bonneau,
Paul L Bellamy,
Peter C Chow,
Peter E Baker,
Pratik S Upadhyay, DDC,
Qin Xu,
Rajiv R Srivastava,
Ralph A Erickson,
Ralph H Vocque,
Raquel Gonzalez Rivera,
Reba A Gates,
Rebecca Rodriguez,
Regina T Brown,
Richard E Needham,
Richard L Rutherford,
Robert J Martin,
Rochelle L Campbell,
Roger F Zabinski,
Rosario D'costa,
Russell J Glapion,
Samuel T Walker,
Santos E Camara,
Sarah E Mcmullen,
Satheesh Thomas,
Scott T Ballard,
Sean R Marcsisin,
Sharon K Thoma, PharmD,
Simone E Pitts,
Sneha S Patel,
Stephen D Brown,
Steven A Gonzales,
Steven D Kehoe,
Steven M Weinman,
Susan W Ting,
Susanna E Ford,
Syed N Ali,
Taichun Qin, PhD,
Tamil Arasu, PhD,
Tara G Bizjak,
Tara R Gooen,
Temar Q Williams,
Tina M Pawlowski,
Unnee Ranjan,
William A Warnick,
William D Tingley,
Yasamin Ameri,
Yoriann M Cabrera Bartolomei,
Yumi J Hiramine,
Yvesna C Blaise,
Yvette I Henry,
Yvette I Johnson,
Yvins Dezan,
Yvonne C Mcknight,
Yvonne E Lozano,
Zachary A Bogorad
Rochelle L Cross's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2020 | FDA 483 | Patricia Kropf MD - Form 483, 2020-11-13 |
November, 2003 | FDA 483 | Complete Analysis Laboratories Inc - Form 483, 2003-11-21 |
March, 2018 | FDA 483 | Giacomina Massaro-Giordano M.D. - Form 483, 2018-03-09 |
November, 2003 | EIR | Complete Analysis Laboratories Inc - EIR, 2003-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more